United States
Print page content Print
Increase text size Decrease text size
Text Size

Proven Efficacy

BRD CONTROL

Significantly lower morbidity than Micotil®

A study of 4,080 animals was conducted to compare the efficacy of a single dose of EXCEDE® (1.5 mL/100 lbs.) to a single dose of Micotil® (tilmicosin, 1.5 mL/100 lb.) for metaphylactic BRD control.1

Morbidity at Day 15

At Day 15, morbidity was considerably lower (P < 0.05) for cattle treated with EXCEDE with a seven-day post-metaphylaxis interval (PMI)* than for cattle treated with Micotil with a three-day PMI or negative control cattle.1

Read about the study >

 

BRD TREATMENT

Better treatment success than Baytril®2

In a three-site study of 1,760 cattle, a single dose of EXCEDE followed by a seven-day post-treatment interval (PTI)* significantly increased 56-day treatment success compared with a three-day PTI using a single dose of EXCEDE or Baytril.2

56-day treatment success

 

Fewer treatment failures than Baytril2

Cattle treated with EXCEDE followed by a seven-day PTI resulted in fewer treatment failures than did EXCEDE with a three-day PTI or Baytril followed by a three-day PTI.2

Cumulative retreatments

Read about the studies >

 

IMPORTANT SAFETY INFORMATION FOR CATTLE: People with known hypersensitivity to penicillin or cephalosporins should avoid exposure to EXCEDE. EXCEDE is contraindicated in animals with known allergy to ceftiofur or to the ß-lactam group (penicillins and cephalosporins) of antimicrobials. Inadvertent intra-arterial injection is possible and fatal. Do not use in calves to be processed for veal. Pre-slaughter withdrawal time is 13 days following the last dose. See full Prescribing Information.

 

References

 

 

Baytril is a registered trademark of Bayer. Micotil is a registered trademark of Eli Lilly and Company. Nuflor and Zuprevo are trademarks of Merck Animal Health. Zactran is a registered trademark of Merial.